Evolent Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -129.8% | – | -86.8% | +107.0% | |
| – | +0.0% | +140.4% | +87.9% | +37.5% | +49.7% | -7.7% | -2.3% | +11.9% | +83.7% | +1.8% | -2.4% | |
| – | – | +52.8% | -9.2% | -13.8% | -11.3% | -6.5% | +14.4% | +103.3% | +19.2% | -1.9% | 0.0% | |
| – | -1,476.9% | – | -91.1% | +18.5% | +903.0% | +47.8% | -93.9% | -258.3% | – | – | – | |
| – | – | -305.2% | – | – | – | -16,812.7% | – | – | – | -632.4% | – | |
| – | -41.0% | +138.3% | +79.4% | +42.0% | -10.2% | -17.1% | -15.2% | +53.5% | -25.1% | -13.4% | +36.9% | |
| – | +1,121.6% | +123.9% | -87.5% | +1,207.6% | +13.3% | – | -106.0% | +1,541.4% | +60.4% | -84.9% | -99.6% | |
| – | – | – | – | – | – | -67.3% | -93.5% | +1,044.9% | +26.3% | +6.9% | -44.6% | |
| – | -0.1% | -100.2% | +248.5% | -2.8% | +111.1% | +567.8% | – | -187.0% | +46.6% | +8.7% | +140.6% | |
| – | +0.0% | +0.0% | -103.5% | – | -115.8% | – | -834.6% | – | -16.6% | -68.0% | +11.1% | |
| – | – | -41.6% | +35.5% | +65.5% | -113.0% | -66.6% | +149.1% | – | +113.9% | -100.2% | +6,258.2% | |
| – | – | -107.7% | – | -25.8% | -382.3% | – | -102.8% | – | – | -641.8% | – | |
| – | – | – | – | – | – | – | – | -462.6% | – | -105.4% | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.